Development and validation of a risk stratification score for new-onset atrial fibrillation in STEMI patients undergoing primary percutaneous coronary intervention.
Annamaria MazzoneMarco ScaleseUmberto ParadossiSerena Del TurcoNicoletta BottoAlberto De CaterinaGiuseppe TrianniMarcello RavaniAntonio RizzaSabrina MolinaroCataldo PalmieriSergio BertiGiuseppina BastaPublished in: International journal of clinical practice (2018)
The ALBO risk score, comprising biomarkers and clinical variables that can be assessed in hospital setting, could help to identify high-risk patients for NOAF after pPCI so that a prompter action can be taken.
Keyphrases
- percutaneous coronary intervention
- atrial fibrillation
- patients undergoing
- st segment elevation myocardial infarction
- end stage renal disease
- st elevation myocardial infarction
- acute coronary syndrome
- ejection fraction
- coronary artery disease
- acute myocardial infarction
- chronic kidney disease
- antiplatelet therapy
- newly diagnosed
- healthcare
- coronary artery bypass grafting
- heart failure
- prognostic factors
- direct oral anticoagulants
- left ventricular
- venous thromboembolism
- catheter ablation
- oral anticoagulants
- coronary artery bypass
- acute care
- electronic health record